Among mCRPs, CD55 (decay-accelerating factor (DAF)) accelerates the degradation of C3 convertase and has been reported to be overexpressed on the cell surface of various cancers, particularly breast cancer25, leukemia26, colorectal cancer27, and gastric cancer28. This evidence concerns the gene CD55 and cancer.